# Research Pipeline Final Report

## Outcome: SUCCESS
## Total Phases Executed: 4
## Rethinks Used: 0

---

## Phase 1: THINK
- **Methodology**: KG-DAP (Knowledge-Graph-Driven Adaptive Prior) — a finite Beta mixture prior with power-sharpened, knowledge-graph-derived borrowing weights for clinical trials
- **Comparators**: rMAP (Schmidli 2014), Uniform Beta(1,1), Pooled Beta, Equal-Weight Mixture
- **Key design decisions**:
  - Beta mixture for conjugate closure, closed-form computation, and pre-specifiability
  - Power-based similarity weights (validated replacement for diffusion kernel)
  - Built-in robustness via vague component (w_0 = 0.20)
  - Composite similarity from drug Jaccard, target Jaccard, population features

## Phase 2: VALIDATE
- **Verdict**: GO
- **Primary advantage**: MAE 0.1257 vs 0.1697 (rMAP), 25.9% relative improvement, CI confirmed by deterministic LOO-CV
- **Key limitation**: Vulnerable to adversarial high-similarity contamination (sim >= 0.90); naturally robust at realistic similarity levels
- **Iterations**: 2 (diffusion kernel failed → power-based weights succeeded)
- **Rethinks**: 0
- **Critical discovery**: Diffusion kernel exp(-β·L) produces near-uniform weights on dense graphs due to eigenvalue compression in normalized Laplacian. Power-based weights ω_k = S_{c,k}^β / Σ S_{c,j}^β directly amplify similarity differences.

## Phase 3: WRITE
- **Manuscript**: pipeline/phase4_polish/round_2/manuscript.tex (final version)
- **Pages**: 30 (double-spaced)
- **Figures**: 6 (LOO-CV MAE, arm-level scatter, sensitivity β, ablation, contamination, sensitivity w_0)
- **Tables**: 6 main + 3 supplementary
- **Evaluation types**: LOO-CV, sensitivity analysis (β, w_0), contamination robustness, component contribution analysis, simulation study (B=1000, bootstrap CIs), design operating characteristics

## Phase 4: POLISH
- **Starting score**: 40/50
- **Final score**: 42/50 (Grade A)
- **Rounds**: 3 (Grade R0, Fix+Grade R1, Fix+Grade R2)
- **Issues fixed**:
  - R1: MC SE claim, dead bib entries, terminology standardization, seed reproducibility, posterior ESS, supplementary material, added design OC section, increased simulation B to 1000
  - R2: Drug-Only delta rounding, bootstrap CIs to 4dp, Proposition 2 proof expansion

## Score Breakdown

| Dimension    | R0 | R1 | R2 (Final) |
|-------------|----|----|------------|
| Correctness  | 4  | 4  | 4          |
| Completeness | 4  | 5  | 5          |
| Rigor        | 4  | 4  | 4          |
| Clarity      | 4  | 4  | 5          |
| Novelty      | 4  | 4  | 4          |
| Impact       | 4  | 4  | 4          |
| Performance  | 4  | 4  | 4          |
| **Raw Total**    | **28/35** | **29/35** | **29/35** |
| **Weighted Total** | **40/50** | **41/50** | **42/50** |

## Lessons Learned
- **What worked well**:
  - The THINK → VALIDATE → WRITE → POLISH pipeline prevented the v1 failure mode (writing before validating)
  - Phase 2 validation caught the diffusion kernel failure BEFORE a full paper was written, saving enormous effort
  - Power-based weights were discovered and validated within Phase 2's 3-iteration budget
  - The grader's feedback was actionable — each round produced concrete, fixable issues
  - Design OC addition in Round 1 was the single most impactful fix (Completeness 4→5)

- **What didn't work**:
  - The original diffusion kernel specification failed on dense graphs — the methodology architect's theoretical elegance didn't survive contact with real data
  - Round 1 fixer introduced a rounding error while "fixing" a correct value — automated fixes need verification
  - Self-grader flagged 2 bib entries as dead that were actually cited — grader accuracy isn't perfect
  - B=200 simulation was insufficient for Biometrics standards — should have been B=1000 from Phase 3

- **Suggestions for next run**:
  - Have Phase 3 use B=1000 directly (not B=200 followed by upgrade in Phase 4)
  - Include design OC in the Phase 3 mandate (not just Phase 4 fix)
  - Add a verification step after each fixer round to catch regressions before re-grading
  - Consider a second disease area to address the single-domain limitation (Novelty/Impact 4→5 potential)

## All Files Produced

### Phase 1: THINK
- `pipeline/phase1_think/methodology_specification.md` — Updated method specification (power-based weights)
- `pipeline/phase1_think/methodology_rationale.md` — Design decisions and reasoning
- `pipeline/phase1_think/briefings/literature_briefing.md` — Literature context

### Phase 2: VALIDATE
- `pipeline/phase2_validate/validation_report.md` — GO verdict with full quantitative evidence
- `pipeline/phase2_validate/iteration_log.md` — Iteration-by-iteration record
- `pipeline/phase2_validate/validated_code/kg_dap.py` — KG-DAP implementation
- `pipeline/phase2_validate/validated_code/comparators.py` — 4 comparator implementations
- `pipeline/phase2_validate/validated_code/run_validation.py` — Validation runner
- `pipeline/phase2_validate/validated_results/` — 8 CSVs + 6 PNG figures

### Phase 3: WRITE
- `pipeline/phase3_write/manuscript.tex` — Initial manuscript (645 lines)
- `pipeline/phase3_write/manuscript.pdf` — Compiled PDF
- `pipeline/phase3_write/references.bib` — 20 bibliography entries
- `pipeline/phase3_write/figures/` — 6 PDF figures
- `pipeline/phase3_write/data/` — 8 CSV data files
- `pipeline/phase3_write/generate_figures.py` — Figure generation script
- `pipeline/phase3_write/run_simulation_v3.py` — Simulation runner
- `pipeline/phase3_write/decision_log.md` — Writing decisions
- `pipeline/phase3_write/briefings/` — Literature and modeling briefings

### Phase 4: POLISH (Final versions)
- `pipeline/phase4_polish/round_2/manuscript.tex` — **FINAL manuscript**
- `pipeline/phase4_polish/round_2/manuscript.pdf` — **FINAL compiled PDF**
- `pipeline/phase4_polish/round_2/references.bib` — **FINAL bibliography (17 entries)**
- `pipeline/phase4_polish/round_2/figures/` — 6 PDF figures
- `pipeline/phase4_polish/round_0/paper_grade.md` — Round 0 grade (40/50)
- `pipeline/phase4_polish/round_1/paper_grade.md` — Round 1 grade (41/50)
- `pipeline/phase4_polish/round_2/paper_grade.md` — Round 2 grade (42/50, Grade A)

### Pipeline Infrastructure
- `pipeline/pipeline_log.md` — Append-only master log
- `pipeline/pipeline_state.md` — Resumable checkpoint
- `pipeline/final_report.md` — This report
